Search Results for: covid

Weekly reads: stem cell therapy for eyes research, DMD, cheating death, cancer sensors

/ / 1 Comment
stem cell therapy

Many avenues are being pursued to get stem cell therapy to the clinic for eye conditions. These different approaches employ a variety of stem cell types. In some cases, such as with iPS cells, the stem cells themselves are not transplanted. Instead, the iPS cells are used to make differentiated eye cells, such as RPE […]

Weekly reads: stem cell therapy for eyes research, DMD, cheating death, cancer sensors Read More »

Weekly reads: BioCardia, HeLa suit, illegal bio lab in CA

/ / Leave a Comment
mesenchymal cells

A days ago the news came about Mesoblast not getting FDA approval for its MSC product for GvHD. The MSC area has had a rough few years with various clinical trials including for COVID. The “stem cells for heart disease” arena has also had a tough time. Here’s more news along these lines: BioCardia pauses enrollment in PhIII trial

Weekly reads: BioCardia, HeLa suit, illegal bio lab in CA Read More »

Weekly reads: MD Stem Cells, embryo models & headaches, cell therapy trial updates

/ / Leave a Comment
dr. jeffrey weiss, MD Stem Cells

There is still plenty of reason to worry about unproven stem cells being marketed in the U.S. and elsewhere around the world. I’ll start with a new item here in the U.S. on a firm called MD Stem Cells and end with a newly published paper about how things are going in Poland on this

Weekly reads: MD Stem Cells, embryo models & headaches, cell therapy trial updates Read More »

Where Kimera Labs fits into sphere of exosome companies

/ / 4 Comments
Kimera labs exosome

Today’s post takes a close look at the exosome manufacturer Kimera Labs in the context of the main exosome companies. What are exosomes? Exosomes are microscopic bubbles or vesicles produced by cells. Exosomes contain many cellular substances that are biologically active. Some of these materials may be helpful clinically, while others could pose risks. Clinical outcomes

Where Kimera Labs fits into sphere of exosome companies Read More »

Weekly reads: bat stem cells & viruses, Lineage Cell, He Jiankui visa

/ / Leave a Comment
bat stem cells, stem cells

Occasionally when I write a post there is an angry reaction to it in the blog comments, which was the case for my recent fact-check of the LifeWave X39 patches.  As you can see in that post, I didn’t find convincing data to either back up the claimed stem cell connection. In my opinion, there

Weekly reads: bat stem cells & viruses, Lineage Cell, He Jiankui visa Read More »

Does NurOwn from BrainStorm Cell Therapeutics still provide hope for ALS?

/ / Leave a Comment
Chaim Lebovits, CEO of BrainStorm Cell Therapeutics.

What is the cell therapy for ALS called NurOwn? How strong is its potential as a treatment for ALS? I’ve been following the biotech BrainStorm Cell Therapeutics for many years. Patients keep asking me about NurOwn ALS prospects. They’re looking for hope. Today’s post is a close look at NurOwn and at BrainStorm as a

Does NurOwn from BrainStorm Cell Therapeutics still provide hope for ALS? Read More »

3rd Invitrx warning highlights FDA oversight weakness

/ / 8 Comments

The FDA seems oddly slow in oversight of unproven stem cell clinic-related firms like one here in California called Invitrx Therapeutics. I’ve written before about Invitrx, but interactions between them and the FDA have continued including a new warning letter. It’s become a puzzling situation. More broadly, the FDA has done relatively little in the past

3rd Invitrx warning highlights FDA oversight weakness Read More »